La Manna, F., De Menna, M., Patel, N., Karkampouna, S., De Filippo, M. R., Klima, I., . . . Kruithof-de Julio, M. (2020). Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity. Front Oncol.
Čikaški stil citiranjaLa Manna, Federico, et al. "Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity." Front Oncol 2020.
MLA način citiranjaLa Manna, Federico, et al. "Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity." Front Oncol 2020.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.